Kloth Kloth M M Ruesseler Ruesseler V V Engel Engel C C Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer Gut Gut 2016 2016 65 65 1296 1296 1305 1305 10.1136/gutjnl-2014-309026 10.1136/gutjnl-2014-309026 supplied-pmid 26001389? Here, ERBB2 is linked to colorectal cancer.